Meeting report of the 6th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma

被引:0
|
作者
Merz, Maximilian [1 ]
Raab, Marc S. [1 ,2 ]
Goldschmidt, Hartmut [1 ,3 ]
Hillengass, Jens [1 ,4 ]
机构
[1] Univ Heidelberg Hosp, Hematol Oncol & Rheumatol, Neuenheimer Feld 410, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, Max Eder Grp Expt Therapies Hematol Malignancies, Heidelberg, Germany
[3] Natl Ctr Tumor Dis, Heidelberg, Germany
[4] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany
关键词
Multiple myeloma; Autologous transplantation; Daratumumab; Elotuzumab; Ixazomib; Carfilzomib;
D O I
10.1007/s00432-017-2463-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The 6th Heidelberg Myeloma Workshop was held on May 5th and 6th, 2017 in the lecture hall of the University Hospital Heidelberg. Main topics of the meeting were (1) biology and genomics of multiple myeloma, (2) diagnostics and prognostic factors, (3) role of immunotherapy in multiple myeloma, as well as (4) therapy of multiple myeloma-drugs and treatment strategies. The landscape for the treatment of newly diagnosed and relapsed disease has significantly changed since the last Heidelberg Myeloma Workshop in 2015. Updates on the current developments were presented at the meeting.
引用
收藏
页码:2521 / 2526
页数:6
相关论文
共 36 条